Foundation for Innovative New Diagn
$5,000,000.00 CAD
- Ministère
- Global Affairs Canada
- Programme
- —
- Pays bénéficiaire
- Canada
- Exercice financier
- 2022-2023
- Période de l'entente
- 27 janvier 2023 – 31 mars 2025
- Référence
- CA-3-P009757003
Objet publié
This project builds on Canada’s funding to the Foundation for Innovative New Diagnostics (FIND) during COVID-19. The initial project aims at accelerate the roll-out of safe, affordable, and effective COVID-19 diagnostics in Low- and Lower-Middle Income Countries. This project supports FIND in using testing technologies developed during COVID-19 to expand the range of diseases detected with a single test. This includes other respiratory diseases, sexually transmitted infections, and Human papillomavirus (HPV)-based screening for cervical cancer. The project aims to increase testing for the most marginalized, including women, children, and vulnerable groups. Project activities include: (1) supporting the development of more straightforward sample collection methods, including self-sampling; and (2) conducting in-country customer preference surveys and barrier-to-access surveys to guide the final development and introduction of tests.
Étiquettes communautaires
Les étiquettes sont appliquées par les lecteurs, pas par ce site. Une étiquette par personne par enregistrement.